Healthcare provider profile · identity verified

Tracey Pool Simmons, NP

Nurse Practitioner · ASHEVILLE, NC · NPI 1912187279

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	307	34
Pantoprazole Sodium	Pantoprazole Sodium	279	43
Rosuvastatin Calcium	Rosuvastatin Calcium	248	31
Furosemide	Furosemide	228	34
Levothyroxine Sodium	Levothyroxine Sodium	216	33
Losartan Potassium	Losartan Potassium	192	25
Sertraline Hcl	Sertraline Hcl	169	28
Metoprolol Succinate	Metoprolol Succinate	152	18
Famotidine	Famotidine	148	21
Trazodone Hcl	Trazodone Hcl	145	26
Duloxetine Hcl	Duloxetine Hcl	137	15
Atorvastatin Calcium	Atorvastatin Calcium	133	28
Memantine Hcl	Memantine Hcl	130	16
Donepezil Hcl	Donepezil Hcl	112	15
Amlodipine Besylate	Amlodipine Besylate	111	19
Clopidogrel	Clopidogrel Bisulfate	110	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	99	22
Eliquis	Apixaban	95	16
Potassium Chloride	Potassium Chloride	95	12
Lisinopril	Lisinopril	88	12
Escitalopram Oxalate	Escitalopram Oxalate	85	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	82	suppressed
Alendronate Sodium	Alendronate Sodium	78	13
Lorazepam	Lorazepam	76	23
Pravastatin Sodium	Pravastatin Sodium	75	12
Buspirone Hcl	Buspirone Hcl	72	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	68	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	13
Metoprolol Tartrate	Metoprolol Tartrate	63	11
Mirtazapine	Mirtazapine	62	suppressed
Carvedilol	Carvedilol	57	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	57	40
Tramadol Hcl	Tramadol Hcl	53	12
Levetiracetam	Levetiracetam	50	suppressed
Prednisone	Prednisone	50	15
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	22
Allopurinol	Allopurinol	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Trospium Chloride	Trospium Chloride	41	suppressed
Trulicity	Dulaglutide	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Spironolactone	Spironolactone	37	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	19
Metformin Hcl	Metformin Hcl	35	suppressed
Valsartan	Valsartan	35	suppressed
Omeprazole	Omeprazole	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Insulin Aspart Flexpen	Insulin Aspart	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Finasteride	Finasteride	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	17
Propranolol Hcl	Propranolol Hcl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	22
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Novofine 32	Pen Needle, Diabetic	27	12
Atenolol	Atenolol	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	12
Baclofen	Baclofen	23	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Topiramate	Topiramate	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Digoxin	Digoxin	19	suppressed
Rexulti	Brexpiprazole	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Linzess	Linaclotide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Primidone	Primidone	12	suppressed
Velphoro	Sucroferric Oxyhydroxide	12	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nystatin	Nystatin	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error